He developed a nose drops to prevent meningococcal disease

British scientists are developing and testing a nasal drug that contains beneficial bacteria that colonize the nasal cavity to prevent it.

According to The Daily Mail, scientists at the Southampton Biomedical Research Center, UK, are developing a nose drops containing beneficial bacteria that can prevent the development of meningococcal disease. Currently, the drug is being tested.

About 10% of adults carry bacteria that cause meningitis.

The scientists introduced a gene into the safe Neisseria lactamica species. That gene helps the Neisseria lactamica bacteria stay in the nose (making it easier for bacteria to attach to the mucous cells), causing an immune defense against their relatives, the bacterium Neisseria meningitides that can cause disease. meningitis.

About 10% of adults carry bacteria that cause meningitis. These bacteria live in the nose or throat, without any special expression. But sometimes these bacteria get into the bloodstream and then serious problems start. According to Professor Robert Read, director of the center, if the Neisseria lactamica bacterium exists in the nasal cavity, there is no room left. Whichever is more dangerous for invading microorganisms.

Every year in the UK there are 1,500 cases of meningococcal disease, which can be fatal after 4 hours from the onset of symptoms.